Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWitan Regulatory News (WTAN)

  • This share is currently suspended. It was suspended at a price of 266.00
  • There is currently no data for WTAN

QuotedData's Weekly News & Interview

17 Mar 2023 16:00

RNS Number : 4165T
Witan Investment Trust PLC
17 March 2023
 

QuotedData's Investment Trust Weekly News Round-up Show - James Hart from Witan Investment Trust

On the 17th of March, James Carthew and Richard Williams talked through the Weekly News and interviewed James Hart from Witan Investment Trust - Watch Here.

About our Weekly Show:

The best way to enjoy the show is to join our weekly webinar live, at 11 am every Friday, where we discuss the key stories and events in the investment companies' sector over the last week. We also invite a guest every week and give you the opportunity to get answers to your questions.

Click here to view our previous recordings: https://quoteddata.com/events/?past=true

Click here to view our upcoming events: https://quoteddata.com/events/

This information is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. QuotedData is a trading name of Marten & Co Limited, which is authorised and regulated by the Financial Conduct Authority. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.

QUOTEDDATA50 Gresham Street | London | EC2V 7AY | UKTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFDFIWEDSEDD
Date   Source Headline
2nd Oct 202412:42 pmRNSNet Asset Value(s)
1st Oct 202412:48 pmRNSNet Asset Value(s)
1st Oct 202412:00 pmRNSResults of Scheme Elections
1st Oct 202411:48 amRNSTotal Voting Rights
30th Sep 20242:02 pmRNSNet Asset Value(s)
30th Sep 20241:53 pmRNSResult of Meetings
27th Sep 202412:58 pmRNSNet Asset Value(s)
26th Sep 202412:47 pmRNSNet Asset Value(s)
25th Sep 20245:21 pmRNSTransaction in Own Shares
25th Sep 20242:11 pmRNSNet Asset Value(s)
24th Sep 202412:30 pmRNSNet Asset Value(s)
23rd Sep 20245:22 pmRNSTransaction in Own Shares
23rd Sep 20241:02 pmRNSNet Asset Value(s)
20th Sep 20245:26 pmRNSTransaction in Own Shares
20th Sep 202412:43 pmRNSNet Asset Value(s)
19th Sep 20245:31 pmRNSTransaction in Own Shares
19th Sep 202412:26 pmRNSNet Asset Value(s)
18th Sep 20245:30 pmRNSTransaction in Own Shares
18th Sep 20241:05 pmRNSNet Asset Value(s)
17th Sep 20245:31 pmRNSTransaction in Own Shares
17th Sep 20244:51 pmRNSDirector/PDMR Shareholding
17th Sep 202412:31 pmRNSNet Asset Value(s)
16th Sep 20245:35 pmRNSTransaction in Own Shares
16th Sep 20243:54 pmRNSPortfolio Listing as at 31 August 2024
16th Sep 20243:51 pmRNSMonthly Factsheet as at 31 August 2024
16th Sep 202412:52 pmRNSNet Asset Value(s)
13th Sep 20245:07 pmRNSTransaction in Own Shares
13th Sep 202412:56 pmRNSNet Asset Value(s)
12th Sep 20245:18 pmRNSTransaction in Own Shares
12th Sep 20243:00 pmRNSPublication of Circular
12th Sep 202412:36 pmRNSNet Asset Value(s)
11th Sep 20245:27 pmRNSTransaction in Own Shares
11th Sep 20242:45 pmRNSNet Asset Value(s)
10th Sep 20245:24 pmRNSTransaction in Own Shares
10th Sep 202412:30 pmRNSNet Asset Value(s)
9th Sep 20245:13 pmRNSTransaction in Own Shares
9th Sep 202412:41 pmRNSNet Asset Value(s)
6th Sep 20245:10 pmRNSTransaction in Own Shares
6th Sep 20242:36 pmRNSNet Asset Value(s)
5th Sep 20244:59 pmRNSTransaction in Own Shares
5th Sep 202412:56 pmRNSNet Asset Value(s)
4th Sep 20245:13 pmRNSTransaction in Own Shares
4th Sep 20242:05 pmRNSNet Asset Value(s)
3rd Sep 20245:09 pmRNSTransaction in Own Shares
3rd Sep 20241:23 pmRNSNet Asset Value(s)
2nd Sep 20244:59 pmRNSTransaction in Own Shares
2nd Sep 202412:26 pmRNSNet Asset Value(s)
2nd Sep 20249:43 amRNSTotal Voting Rights
30th Aug 20245:00 pmRNSTransaction in Own Shares
30th Aug 20241:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.